Simulations Plus (NASDAQ:SLP) Share Price Passes Above 200 Day Moving Average – What’s Next?

Simulations Plus, Inc. (NASDAQ:SLPGet Free Report) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $16.32 and traded as high as $20.60. Simulations Plus shares last traded at $20.26, with a volume of 293,847 shares changing hands.

Analyst Ratings Changes

SLP has been the topic of a number of research analyst reports. KeyCorp restated a “sector weight” rating on shares of Simulations Plus in a research note on Wednesday, October 29th. BTIG Research cut Simulations Plus from a “buy” rating to a “neutral” rating in a research note on Thursday, December 18th. TD Cowen raised their price objective on Simulations Plus from $16.00 to $19.00 and gave the stock a “hold” rating in a report on Thursday, January 8th. Zacks Research upgraded Simulations Plus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 28th. Finally, Cowen restated a “hold” rating on shares of Simulations Plus in a research note on Thursday, January 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Simulations Plus has an average rating of “Hold” and an average target price of $25.00.

Check Out Our Latest Report on Simulations Plus

Simulations Plus Stock Up 1.9%

The company has a market cap of $408.24 million, a PE ratio of -6.33 and a beta of 1.09. The firm has a 50 day simple moving average of $18.46 and a 200-day simple moving average of $16.32.

Simulations Plus (NASDAQ:SLPGet Free Report) last released its quarterly earnings results on Thursday, January 8th. The technology company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.05). Simulations Plus had a negative net margin of 81.66% and a positive return on equity of 14.02%. The firm had revenue of $18.42 million for the quarter, compared to analysts’ expectations of $18.05 million. During the same period in the previous year, the company posted $0.17 earnings per share. As a group, equities analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Hedge Funds Weigh In On Simulations Plus

A number of large investors have recently made changes to their positions in the business. North Star Investment Management Corp. increased its holdings in shares of Simulations Plus by 195.6% during the third quarter. North Star Investment Management Corp. now owns 168,130 shares of the technology company’s stock valued at $2,534,000 after acquiring an additional 111,255 shares in the last quarter. Tributary Capital Management LLC boosted its stake in Simulations Plus by 214.7% in the 3rd quarter. Tributary Capital Management LLC now owns 1,136,980 shares of the technology company’s stock worth $17,134,000 after purchasing an additional 775,704 shares in the last quarter. Versor Investments LP purchased a new stake in Simulations Plus during the 2nd quarter worth approximately $496,000. Prescott Group Capital Management L.L.C. acquired a new position in Simulations Plus during the 2nd quarter valued at approximately $1,396,000. Finally, Stephens Investment Management Group LLC purchased a new position in shares of Simulations Plus in the second quarter worth $4,687,000. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Company Profile

(Get Free Report)

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.

See Also

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.